West Virginia Attorney General Patrick Morrisey said the state will receive more than $153,000 in a national settlement with a prescription drug manufacturer.
Morrisey says in a news release last month that every state and the District of Columbia are participating in the $13.5 million settlement with Boehringer Ingelheim Pharmaceuticals Inc.
The settlement resolves allegations that the company misrepresented the effectiveness of four drugs in treating or managing certain health conditions, including heart attacks, congestive heart failure and chronic obstructive pulmonary disease. The drugs are Micardis, Aggrenox, Atrovent and Combivent.
Topics Virginia
Was this article valuable?
Here are more articles you may enjoy.
What Analysts Are Saying About the 2026 P/C Insurance Market 
US Appeals Court Rejects Challenge to Trump’s Efforts to Ban DEI 
Q4 Global Commercial Insurance Rates Drop 4%, in 6th Quarterly Decline: Marsh 
Allstate Doubles Q4 Net Income While Auto Underwriting Income Triples 
